Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2020-07-13 Earnings Release
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
2020年半年度业绩预告公告
Earnings Release Classification · 95% confidence The document is titled as a '2020 Half-Year Performance Forecast Announcement' and contains preliminary estimated financial results for the half-year period from January 1, 2020 to June 30, 2020. It explicitly states that the forecast is unaudited and provides comparative figures from the previous year. The document is relatively short (1436 characters) and serves as an earnings forecast rather than a full interim report with detailed financial statements or analysis. It also includes a risk warning and notes that the final accurate financial data will be disclosed in the formal half-year report. This type of document is best classified as an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results highlighting key figures and outlook without full detailed financial statements. H1 2020
2020-07-13 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司首次公开发行部分限售股上市流通的核查意见
Regulatory Filings
2020-07-13 Chinese
关于涉及诉讼的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding ongoing litigation involving the company and its subsidiary. It details the lawsuit's background, parties involved, claims, and potential impact on the company. There are no financial statements, management discussion of financial results, or other report contents. The document is a legal proceeding update, not a full audit report or annual report. It is not a certification or a brief notice of report publication. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length is 1922 characters, which is consistent with a detailed announcement rather than a full report.
2020-05-31 Chinese
2019年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2019 annual equity distribution (dividend payment) by the company 南微医学科技股份有限公司. It details the dividend amount per share, relevant dates for record, ex-dividend, and payment, tax treatment for different shareholder categories, and the method of dividend distribution. It references the 2019 fiscal year but does not contain financial statements or comprehensive financial data. The document is a formal announcement of dividend distribution details rather than a full financial report or earnings release. Therefore, it fits the category of Notice of Dividend Amount (DIV). The document length is 2216 characters, which is consistent with an announcement rather than a full report.
2020-04-29 Chinese
关于聘任公司高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of senior management personnel at the company 南微医学科技股份有限公司. It details the board meeting resolution to appoint several individuals as senior vice presidents, including their resumes. There is no financial data, no discussion of financial results, no regulatory certifications, or report publications. The content focuses solely on management changes. According to the filing definitions, announcements of changes in senior management fall under 'Board/Management Information' (Code: MANG). The document length is 2367 characters, which is consistent with a typical management announcement rather than a full report or regulatory filing. Therefore, the correct classification is MANG with high confidence.
2020-04-28 Chinese
独立董事关于聘任公司高级副总裁的独立意见
Regulatory Filings
2020-04-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.